Doctors treat a brain bleed with a fast-moving combination of imaging, blood pressure control, medication adjustments, and sometimes surgery, with the exact steps depending on where the bleeding is, what caused it, and how severe it is. A brain bleed, broadly called an intracranial hemorrhage, is a medical emergency in every case, but the treatments vary dramatically between, say, a small bleed from high blood pressure and a massive hemorrhage from a ruptured aneurysm. Understanding the sequence of what happens in the hospital can help patients and families make sense of a frightening and often confusing situation.
How Doctors Figure Out What They Are Dealing With
The first step is almost always a CT scan of the head, typically done within minutes of arrival. A non-contrast CT scan can show whether blood is present inside the skull and, roughly, where it is. That location matters enormously because it determines everything that follows. If the initial scan raises suspicion that the bleeding is still active or expanding, doctors may follow up with a CT angiography, which uses contrast dye to visualize blood vessels in real time. One finding they look for on CT angiography is something called the “spot sign,” a bright spot within the clot that suggests contrast is actively leaking out of a vessel. A meta-analysis found that the spot sign predicts both expansion of the blood clot and worse functional outcomes, making it a red flag that often accelerates treatment decisions.1PubMed Central. Spot sign as a predictor of hematoma expansion and poor functional outcomes after intracerebral hemorrhage: a systematic review and meta-analysis
Beyond imaging, the medical team simultaneously evaluates level of consciousness, neurological function, and vital signs. They check whether the patient is on blood thinners, because anticoagulant-related bleeds require an entirely different treatment track. All of this assessment happens in parallel with the CT scan rather than after it, because with brain bleeds, every hour of delay can translate into worse outcomes.
Where the Bleeding Is Changes Everything
Not all brain bleeds are alike. The location of the hemorrhage shapes the entire treatment approach. Epidural hematomas, which sit between the skull and the outer brain lining, often result from trauma and can expand rapidly. Subdural hematomas collect beneath that outer lining and are especially common in older adults or people on blood thinners. Both are considered extra-axial bleedings, meaning the blood sits outside the brain tissue itself, and they are among the most common findings after traumatic brain injury.2PubMed Central. Traumatic Epidural and Subdural Hematoma: Epidemiology, Outcome, and Dating
Intracerebral hemorrhage (ICH) is bleeding directly into the brain tissue, most often caused by long-standing high blood pressure or a condition called cerebral amyloid angiopathy. Subarachnoid hemorrhage is bleeding into the fluid-filled space around the brain, frequently caused by a ruptured aneurysm. And while hypertension and amyloid angiopathy account for most spontaneous brain bleeds, a range of less common causes exists as well, including blood vessel malformations, tumors, and clotting disorders, which require their own targeted management.3PubMed. Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Bringing Blood Pressure Down Quickly
For intracerebral hemorrhage, one of the first and most impactful interventions is aggressive blood pressure lowering. The logic is straightforward: high pressure inside the arteries pushes more blood through the ruptured vessel, causing the clot to grow. A larger clot means more brain damage. The INTERACT2 trial, which enrolled over 2,800 patients, showed that aggressively dropping systolic blood pressure to below 140 mm Hg, rather than the older guideline target of below 180 mm Hg, significantly reduced clot growth. Patients who hit that lower target within the first hour had the least clot expansion, averaging about 2.6 mL of growth compared to 5.4 mL in those who took more than six hours to get there.4PubMed. Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage Trial-2 Results
In practice, this means nurses titrate intravenous medications like nicardipine or labetalol, checking blood pressure every few minutes in the early hours. The goal is not just reaching the target but reaching it fast and keeping it stable. The same trial data showed that patients who maintained target blood pressure readings most consistently had the smallest clot growth overall.4PubMed. Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage Trial-2 Results
Reversing Blood Thinners
A significant number of people who develop brain bleeds are on anticoagulant medications for conditions like atrial fibrillation or a history of blood clots. These drugs, which exist specifically to prevent clotting, become dangerous during a hemorrhage. Reversing their effects is one of the most time-sensitive interventions in emergency neurology.
For warfarin, the most established blood thinner, reversal typically involves prothrombin complex concentrate (PCC), fresh frozen plasma, and intravenous vitamin K. PCC works faster than plasma and has become the preferred first-line agent. For newer direct oral anticoagulants like dabigatran, apixaban, and rivaroxaban, the landscape has changed rapidly. Idarucizumab, which specifically reverses dabigatran, received FDA approval and became available in 2015. Andexanet alfa, which reverses the factor Xa inhibitors apixaban and rivaroxaban, followed in 2018.5JAMA Neurology. Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage When these specific antidotes are not available, PCC is used as an alternative.6Stroke. Abstract WP169: Thromboelastography as a Biomarker of Emergent Direct-Acting Oral Anticoagulant Reversal With Prothrombin Complex Concentrates for Intracranial Hemorrhage
In a large study of over 9,400 patients with anticoagulant-related brain bleeds, about 79% received some form of reversal therapy. The rate was higher for warfarin patients (85%) than for those on newer anticoagulants (70%), likely reflecting the longer clinical experience with warfarin reversal protocols.5JAMA Neurology. Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
Controlling Pressure Inside the Skull
A blood clot inside the skull takes up space that the brain normally occupies, and because the skull is rigid, there is nowhere for the brain to go. This rising intracranial pressure can be as dangerous as the bleed itself, compressing healthy brain tissue and cutting off its blood supply. Doctors have several tools to bring that pressure down.
Osmotic agents are the medical first line. Mannitol has been used for decades: given intravenously, it draws fluid out of brain tissue and into the bloodstream, temporarily reducing swelling. Hypertonic saline works by a similar principle but appears to have a more sustained effect on intracranial pressure and also helps maintain blood flow to the brain.7PubMed Central. Hypertonic saline and mannitol in patients with traumatic brain injury: A systematic and meta-analysis Many ICU teams now lean toward hypertonic saline for this reason, though both remain in wide use.
Other pressure-reduction measures include elevating the head of the bed to about 30 degrees, sedation to reduce the brain’s metabolic demand, and in severe cases, controlled hyperventilation, which briefly constricts blood vessels and lowers intracranial volume. These are temporizing measures, buying time for definitive treatment.
When Bleeding Spills Into the Ventricles
The brain has a system of fluid-filled chambers called ventricles, and when blood extends into them, it can block the normal flow of cerebrospinal fluid. The result is hydrocephalus, a dangerous buildup of fluid that further raises intracranial pressure. External ventricular drainage (EVD) is the standard procedure for this complication. A neurosurgeon places a thin catheter through a small hole in the skull into one of the ventricles, allowing both blood-tinged fluid and excess cerebrospinal fluid to drain into an external collection bag.8PubMed Central. Role of external ventricular drainage in the management of intraventricular hemorrhage
EVDs are effective but come with a real risk of infection. Ventriculitis and meningitis are the main concerns, and the risk increases the longer the drain stays in place. These infections are associated with longer ICU stays and worse outcomes.9PubMed Central. External Ventricular Drains and Infection Risk: Duration as the Dominant Predictor—A Systematic Review and Meta-Analysis For this reason, neurosurgeons aim to remove EVDs as soon as the patient can tolerate it, often trialing a clamp on the drain to see if pressure stays acceptable without continuous drainage. Some patients whose hydrocephalus does not resolve end up needing a permanent shunt, a surgically implanted device that reroutes cerebrospinal fluid from the brain to the abdomen.
Surgical Options for Removing the Clot
Not every brain bleed requires surgery to remove the blood clot, but when the clot is large, expanding, or in a location where it threatens vital brain structures, surgical evacuation becomes necessary. Traditional open surgery, or craniotomy, involves removing a piece of skull to access the clot directly. In the most severe cases with massive brain swelling, surgeons perform a decompressive craniectomy, removing a larger section of skull bone and leaving it off temporarily to give the swollen brain room to expand outward rather than compress inward. Outcomes after decompressive craniectomy depend heavily on the patient’s condition at the time of surgery: younger patients, those with a Glasgow Coma Scale score of 8 or above, and those who undergo the procedure early tend to fare better.10PubMed Central. Decompressive craniectomy following brain injury: factors important to patient outcome
An increasingly important alternative is minimally invasive surgery (MIS), which uses smaller incisions and image guidance to reach the clot with a catheter or narrow tube. The MIND trial, a randomized clinical trial comparing MIS against medical management alone, showed that MIS reduced clot volume by a median of about 81%, bringing the remaining hemorrhage down to roughly 6 mL. Nearly 80% of MIS patients ended up with residual clot volumes of 15 mL or less.11JAMA Neurology. Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage: The MIND Randomized Clinical Trial The appeal of MIS is that it achieves substantial clot removal while causing less collateral damage to surrounding brain tissue than open craniotomy. However, MIS is not appropriate for every situation, and irregular-shaped clots can be more technically challenging and carry a higher risk of rebleeding after the procedure.12PubMed Central. Irregular-Shaped Hematoma Predicts Postoperative Rehemorrhage After Stereotactic Minimally Invasive Surgery for Intracerebral Hemorrhage
Treating Ruptured Aneurysms
When a brain bleed is caused by a ruptured aneurysm, the bleeding source itself has to be secured to prevent a second, often fatal, rupture. There are two main approaches: surgical clipping and endovascular coiling. In clipping, a neurosurgeon opens the skull and places a tiny metal clip across the neck of the aneurysm, cutting it off from the circulation permanently. In coiling, a catheter is threaded through a blood vessel in the groin up to the brain, and tiny platinum coils are packed inside the aneurysm to trigger clotting within it.
The trade-offs between these two methods have been studied extensively. Clipping achieves higher rates of complete aneurysm closure and lower rates of the aneurysm coming back, while coiling is associated with lower rates of complications and a better short-term recovery.13PubMed Central. Surgical Clipping Versus Endovascular Coiling in the Management of Intracranial Aneurysms A systematic review and meta-analysis of randomized trials found that coiling reduced unfavorable outcomes at one year in patients who were in relatively good condition before treatment, but the advantage disappeared for patients who arrived in poor neurological condition. Coiling did carry a higher rate of rebleeding compared to clipping.14PubMed. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis In one single-center study of ruptured anterior communicating artery aneurysms, the coiling group had shorter ICU stays and more frequently achieved favorable outcomes, with coiling identified as an independent predictor of good results.15PubMed Central. Outcome of ruptured anterior communicating artery aneurysm treatment compared between surgical clipping and endovascular coiling
In practice, the choice between clipping and coiling depends on the aneurysm’s shape, size, and location, the patient’s overall condition, and the expertise available at the treating hospital. Coiling has become increasingly common over the past two decades, but clipping remains essential for aneurysms that are not amenable to catheter-based treatment.
Preventing Vasospasm After Subarachnoid Hemorrhage
After a subarachnoid hemorrhage, patients face a secondary threat that can be just as devastating as the initial bleed. Blood products sitting in the fluid around the brain irritate the blood vessels, causing them to constrict days later. This delayed narrowing, called vasospasm, can cut off blood supply to large areas of brain tissue, essentially causing a stroke on top of the hemorrhage. The peak risk window is roughly four to fourteen days after the initial bleed.
Nimodipine, a calcium channel blocker, is the standard preventive medication and is given to virtually all subarachnoid hemorrhage patients. It has shown the most consistent improvements in patient outcomes of any vasospasm-related therapy. When vasospasm does develop despite prevention, treatment escalates to what has traditionally been called triple-H therapy, which involves raising the patient’s blood volume, thinning the blood slightly, and driving blood pressure higher to force blood through narrowed vessels.16PubMed Central. Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage In more refractory cases, interventional neuroradiologists can thread a catheter into the narrowed vessels and either inject vasodilating drugs directly or inflate a tiny balloon to physically open them up.
The Debate Over Seizure Prevention
Seizures are a real risk after a brain bleed, occurring in a meaningful minority of patients, particularly those with cortical (surface-level) hemorrhages. Despite this, the question of whether to give anti-seizure medication preventively, before a seizure actually happens, is one of the more contested areas in neurocritical care.
The most recent guidelines from the Neurocritical Care Society suggest avoiding routine preventive anti-seizure medication in adults with nontraumatic intracerebral hemorrhage. When prophylaxis is used, the guidelines favor levetiracetam over older drugs like phenytoin, and only for a short duration of seven days or less.17PubMed. Guidelines for Seizure Prophylaxis in Patients Hospitalized with Nontraumatic Intracerebral Hemorrhage A pooled analysis of existing studies found that preventive anti-seizure medication did not improve long-term neurological function or reduce death rates overall.18PubMed. Antiepileptic Drugs to Prevent Seizures After Spontaneous Intracerebral Hemorrhage
The emerging approach is risk-based rather than blanket prophylaxis. EEG monitoring can help identify patients who are at higher seizure risk based on their brain’s electrical activity; those with higher risk scores may genuinely benefit from short-term prevention, while the majority of patients with low-risk patterns can safely go without it.19JAMA Neurology. Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage At hospitals where EEG is not readily available, the conservative approach of withholding preventive medication for most patients appears reasonable.
The Broader Bundle of ICU Care
Beyond the headline interventions, a brain bleed patient in the ICU receives a web of supportive treatments that collectively influence outcome. Fever is common after brain hemorrhage and independently worsens prognosis, so the team aggressively manages temperature with medications like acetaminophen and, when needed, surface cooling devices. High blood sugar, which is toxic to injured brain tissue, is controlled with insulin. Blood clots in the legs are a frequent complication when patients are immobile, so intermittent compression devices on the legs are standard, with low-dose blood thinners typically introduced cautiously within the first few days.20PubMed Central. Critical Care Management of Acute Intracerebral Hemorrhage
Nutrition, respiratory support, and monitoring for swallowing difficulties (which could cause pneumonia) round out the care bundle. None of these interventions alone is dramatic, but together they form a critical safety net that can meaningfully shift survival and recovery.
How Doctors Estimate Prognosis
Families often ask the hardest question within the first day: what are the chances of recovery? Doctors use several scoring systems to estimate this, the most well-known being the ICH Score, which grades severity based on factors like consciousness level, hemorrhage volume and location, age, and whether blood has extended into the ventricles.21PubMed. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage
One important caveat that families should understand: these scores are more accurate when recalculated at 24 hours than at the time of arrival. A study found that the ICH score at admission was not a statistically significant independent predictor of death, but the same score recalculated at 24 hours was. The odds of mortality roughly tripled for each additional point on the 24-hour score.22PubMed Central. 24-Hour ICH Score Is a Better Predictor of Outcome than Admission ICH Score This matters because early prognostic estimates can be unreliable, and premature pessimism in the first hours can influence treatment decisions in ways that become self-fulfilling. Modified versions of the ICH score have been developed to improve sensitivity, and teams sometimes use multiple scoring systems in parallel to get a more rounded picture.23PubMed Central. Predicting 30-day mortality in patients with primary intracerebral hemorrhage
Goals of Care and End-of-Life Decisions
Brain bleeds force difficult conversations about goals of care more frequently than almost any other medical emergency. Most in-hospital deaths among patients with stroke, traumatic brain injury, and similar severe brain injuries occur after a decision to withhold or withdraw life-sustaining treatment, rather than from the direct failure of organs.24PubMed. End-of-life decisions in patients with severe acute brain injury This means that the decision-making process itself is a major determinant of outcomes, and it is an area where the values of the patient and family carry enormous weight.
For families, the practical takeaway is that early prognostic scores should not be treated as destiny. It is reasonable to ask the medical team to wait at least 24 to 48 hours before making irreversible decisions about treatment withdrawal, because the clinical picture can change considerably in that window. Advance directives and healthcare proxies, decided well before any emergency, remain the best tools for ensuring that what happens in these moments reflects the patient’s own wishes.
Restarting Blood Thinners After the Bleed
For patients who survive a brain bleed while on anticoagulant or antiplatelet therapy, one of the trickiest decisions comes weeks or months later: when, or whether, to restart those medications. The dilemma is real. The blood thinner was prescribed because the patient has a genuine clotting risk, perhaps from atrial fibrillation or mechanical heart valves, and stopping it long-term puts them at risk of a stroke or pulmonary embolism. But restarting it creates a risk of another brain bleed.25PubMed Central. Anticoagulation and Antiplatelet Agent Resumption Timing following Traumatic Brain Injury
There is no universal timeline. Most guidelines suggest waiting at least several weeks, with the exact timing depending on the type and location of the bleed, the reason for the blood thinner, and the patient’s individual risk profile. This decision is typically made collaboratively between neurologists, cardiologists, and hematologists, because it sits at the intersection of competing dangers.
Rehabilitation After a Brain Bleed
Survival is only part of the story. The brain has a significant capacity to rewire itself after injury through a process called neuroplasticity, and rehabilitation is the primary tool for harnessing it. Depending on the deficits a patient has, rehabilitation may involve physical therapy for strength and balance, occupational therapy for daily tasks like dressing and eating, speech therapy for language or swallowing problems, and neuropsychological support for cognitive and emotional changes.26PubMed Central. Recovery and Rehabilitation after Intracerebral Hemorrhage
Recovery timelines vary enormously. Some patients make substantial gains in the first three months, while others continue improving over a year or more. Factors that influence recovery include the size and location of the bleed, the patient’s age and pre-existing health, and how quickly rehabilitation begins. Early mobilization in the hospital, as soon as it is medically safe, is now widely practiced because prolonged bed rest leads to muscle wasting, blood clots, and depression, all of which undermine long-term recovery. For families navigating this phase, the most useful framework is that rehabilitation after a brain bleed is measured in months, not days, and that meaningful progress can continue well after the acute hospitalization is over.